# Effect of Oxalidine Combined with Reduced-opioid Anesthesia on Multimodal Analgesia in Morbidly Obese Patients Undergoing Bariatric Surgery

> **NCT06712199** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Yongtao Sun** · enrollment: 124 (estimated)

## Conditions studied

- Morbid Obesity

## Interventions

- **DRUG:** oxalidine

## Key facts

- **NCT ID:** NCT06712199
- **Lead sponsor:** Yongtao Sun
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-01-01
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 124 (ESTIMATED)
- **Last updated:** 2024-12-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06712199

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06712199, "Effect of Oxalidine Combined with Reduced-opioid Anesthesia on Multimodal Analgesia in Morbidly Obese Patients Undergoing Bariatric Surgery". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT06712199. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*